Former Roche, Alexion Execs Head to Ophthotech

Xconomy New York — 

New York-based Ophthotech (NASDAQ: OPHT) today named former Roche ophthalmology executive David Shima its chief scientific officer. Shima also once worked at Eyetech Pharmaceuticals, which was founded many years ago by current Ophthotech executives. In addition, Ophthotech hired Henric Bjarke, formerly of Alexion Pharmaceuticals (NASDAQ: ALXN), as its chief commercial officer.